DENVER--(BUSINESS WIRE)--TriSalus TM Life Sciences (“TriSalus”), a company committed to transforming outcomes for patients with solid tumors, today announced the launch of its TriNav™ Infusion System ...
WESTMINSTER, Colo.--(BUSINESS WIRE)-- TriSalus Life Sciences (TLSI), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with ...
DENVER & SAN DIEGO--(BUSINESS WIRE)--TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients ...
The Workgroup conducted three surveys that were distributed to NCCN member institutions regarding average patient wait time, chemotherapy premixing practices, infusion chair use, and premedication ...